13-02-2026 08:00 via wallstreet-online.de

CelLBxHealth PLC - Aligning Regulatory Approach with Commercial Needs

CelLBxHealth strengthens cost discipline by aligning FDA regulatory approach with current commercial needs GUILDFORD, SURREY / ACCESS Newswire / February 13, 2026 / CelLBxHealth plc (AIM:CLBX), a leader in circulating tumor cell (CTC) intelligence, …
Weiterlesen »